"Notably, correspondence between the parties and the Commission shows that the defence of RPB is effectively being handled by Aventis Pharma. Correspondence from the lawyers is being copied to [Aventis employee 4] and [Aventis employee 5](139). This connection shows that Aventis Pharma exercises effective influence over RPB".
Recital 211, Decision_act (EU) 2004/104
In forcesince 27 Nov 2002